Clinical Nutrition for Cancer Care Market: Emerging Trends in Personalized Nutrition Support
Polaris Market Research today announced findings from its
latest report, projecting the global
clinical nutrition for cancer care market to grow from USD 4.62
billion in 2023 to USD 7.11 billion by 2032, at a CAGR of 4.9% during the
2024–2032 forecast period. The report profiles ten leading companies across
five market segmentation categories, including type, cancer type, age group,
sales channel and region.
Analyst Commentary on Clinical Nutrition for Cancer Care
Market Growth
“Malnutrition is a real risk for patients undergoing cancer
treatment, and that clinical need is a central driver of market growth for
oncology nutrition,” said a Polaris Market Research analyst. “The opportunity
lies with companies that build clinical evidence, personalize formulations and
reach patients through both hospital and online channels.”
Clinical Nutrition for Cancer Care Market Statistics at a
Glance
- 2024
Market Size: USD 4.83 Billion
- 2032
Projected Size: USD 7.11 Billion
- CAGR
(2024–2032): 4.9%
- Largest
Region (2023): North America
Key Growth Drivers, Major Companies and Segments Covered
Growth Drivers: A growing cancer burden, rising
malnutrition risk among oncology patients, and greater awareness of nutrition
as a complementary therapy are the primary forces behind the market’s
expansion, alongside growing demand for personalized oral nutrition. Cancer
treatment often causes appetite loss and altered taste, raising the need for
nutritional support. The American Cancer Society estimated around 1.9 million
new cancer cases in the U.S. in 2022. Nutritional products can also help
support immune function in patients receiving immuno-oncology drugs.
Major Companies Covered: Nestlé Health Science,
Abbott Nutrition, Danone Nutricia, Baxter, Bayer AG, GlaxoSmithKline plc,
Medtrition, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Victus, Inc. The
market is consolidated, with a few players holding a significant share through
strong product portfolios and global presence.
Segments Covered: By Type (Oral Nutrition, Parenteral
Nutrition, Enteral Feeding Formulas), By Cancer Type (Head & Neck, Stomach
& Gastrointestinal, Blood, Breast, Lung), By Age Group (Adult, Paediatric),
By Sales Channel (Offline, Online), By Region.
👉 Download a Free
Sample of the Clinical Nutrition for Cancer Care Market Report →
https://www.polarismarketresearch.com/industry-analysis/clinical-nutrition-for-cancer-care-market
Segment Insights and Market Restraints
Oral nutrition held the largest share by type in 2023, owing
to ease of consumption and its value for patients with taste disturbances. By
cancer type, lung cancer is projected to expand at a significant CAGR, as
treatment side effects limit nutrient intake from regular food.
The main restraint is limited clinical evidence on
recommended dietary requirements, along with the high price of premium
supplements, regulatory hurdles and differences in dietary habits across
regions.
Market Outlook: Evidence, Personalization and Access
The clinical nutrition for cancer care market is expected to
benefit from greater emphasis on improving treatment outcomes and from the
rising demand for personalized care. Growing research and development, aimed at
generating evidence for the efficacy of nutritional products, is likely to
strengthen physician confidence and broaden prescribing.
Adoption is also increasing in developing countries, where
malnutrition risk among cancer patients is a growing concern. Companies
launching new products for specific cancer types, and expanding across offline
and online sales channels, are positioned to capture this demand. Better
clinical data would help address the main restraint and support wider
reimbursement and awareness over the forecast period.
Recent Developments in the Clinical Nutrition for Cancer
Care Market
- January
2023: Nestlé India expanded its Health Science portfolio with ThickenUp
Clear, a thickening solution for patients with swallowing difficulties
linked to conditions such as head and neck cancer.
- July
2022: Nestlé Health Science introduced “Oral Impact Su Yi Su,” described
as China’s first Food for Special Medical Purpose approved for patients
with tumour conditions.
Regional Snapshot: North America Leads, Asia Pacific
Fastest-Growing
North America led with the largest share in 2023, supported
by a large cancer patient pool, nutritional assessment before treatment
planning in the U.S., and active research and development by market players.
Asia Pacific is projected to register the highest CAGR through 2032 on the back
of rising cancer prevalence, malnourishment among patients, demand for early
detection and growing awareness among doctors and patients.
Why It Matters for Buyers Evaluating the Clinical
Nutrition for Cancer Care Market Forecast
For stakeholders researching the
clinical nutrition for cancer care market forecast, the underlying report
benchmarks market share, company positioning and segment-level projections to
support sourcing, partnership and investment decisions through 2032. It also
covers Porter’s Five Forces, PESTLE analysis and country-level data across five
regions. Manufacturers, healthcare providers and investors can use these
insights to compare product types and to identify high-growth cancer
categories.
About Polaris Market Research
Polaris Market Research is a B2B syndicated market research
and consulting firm offering 5,000+ published reports across 20+ industry
verticals, delivering data-backed insights to help businesses make informed
decisions.
More Trending Latest Reports By Polaris Market Research:
experience-travel-services-market
functional-water-benefits-types-market
europe-chemical-distribution-market
profiling-top-10-firms-in-the-connected-cars-market-2025
Comments
Post a Comment